ROG and CHGCY Related Headlines
Go Back- New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
- Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
- Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
- Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025
- Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
- Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
- Roche gets CE mark for glucose monitor and mySugr app integration
- Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
- Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
- Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
ROG and CHGCY Related Press Releases
Go Back- New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
- Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
- Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
- Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025
- Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
- Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
- Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
- Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
- Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
